• News
  • SAN DIEGO
  • Finance

MabVax Therapeutics closes on first tranche of Series B financing

San Diego-based MabVax Therapeutics Inc., a privately held clinical stage biotechnology company, has announced the closing of the first tranche in its Series B financing.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!